Incyte Named One of Top 5 Companies on Science Magazine’s 2024 Top Employers List
24 Oktober 2024 - 8:03PM
Business Wire
Recognition Among Several Workplace Awards
Received by the Company this Year
Incyte announced today that for the seventh consecutive year, it
has been named a top five biotech and pharma employer based on
Science magazine’s annual survey. This year, Incyte was ranked
third and specifically recognized for its commitment to employee
respect, social responsibility and employee loyalty.
In addition to this recognition, earlier this year Incyte was
also named one of America’s 100 Most Loved Workplaces and one of
the Most Loved Global Workplaces by Newsweek. These honors reflect
Incyte’s continued commitment to fostering innovation, growth and
passion from within.
“Incyte is honored to be recognized once again as a top employer
by Science. This distinction speaks to our commitment to creating
an environment where collaboration, mutual respect and a shared
passion for science and patients are at the forefront,” said Paula
Swain, Executive Vice President, Human Resources, Incyte. “For more
than two decades, we have championed a culture that drives
innovation, empowering our team to tackle new areas of drug
discovery and development, fueled by our drive to Solve On. for
patients. Being recognized as great workplaces by Science magazine,
as well as other prominent industry publications like Newsweek,
reinforces the passion and enthusiasm that motivate us individually
and collectively every day.”
The complete Science magazine Top Employers survey feature,
along with individual company rankings will be included in the
October 25, 2024, print issue of Science and is available now
online here:
https://www.science.org/content/article/top-20-2024-who-did-science-readers-select-best-biopharma
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical
company focused on finding solutions for serious unmet medical
needs through the discovery, development and commercialization of
proprietary therapeutics.
For additional information on Incyte, please visit Incyte.com or
follow us on social media: LinkedIn, X, Instagram, Facebook,
YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241024009669/en/
Media media@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
Von Dez 2023 bis Dez 2024